|
1
|
Anderson JL and Gutmann DH:
Neurofibromatosis type 1. Handb Clin Neurol. 132:75–86.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ferner RE and Gutmann DH:
Neurofibromatosis type 1 (NF1): Diagnosis and management. Handb
Clin Neurol. 115:939–955. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gutmann DH, Ferner RE, Listernick RH, Korf
BR, Wolters PL and Johnson KJ: Neurofibromatosis type 1. Nat Rev
Dis Primers. 3(17004)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ferner RE, Huson SM, Thomas N, Moss C,
Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C
and Kirby A: Guidelines for the diagnosis and management of
individuals with neurofibromatosis 1. J Med Genet. 44:81–88.
2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Feldman DS, Jordan C and Fonseca L:
Orthopaedic manifestations of neurofibromatosis type 1. J Am Acad
Orthop Surg. 18:346–357. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vitale MG, Guha A and Skaggs DL:
Orthopaedic manifestations of neurofibromatosis in children: An
update. Clin Orthop Relat Res. 107–118. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shen MH, Harper PS and Upadhyaya M:
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet.
33:2–17. 1996.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Leskelä HV, Kuorilehto T, Risteli J,
Koivunen J, Nissinen M, Peltonen S, Kinnunen P, Messiaen L,
Lehenkari P and Peltonen J: Congenital pseudarthrosis of
neurofibromatosis type 1: Impaired osteoblast differentiation and
function and altered NF1 gene expression. Bone. 44:243–250.
2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sharma R, Wu X, Rhodes SD, Chen S, He Y,
Yuan J, Li J, Yang X, Li X, Jiang L, et al: Hyperactive Ras/MAPK
signaling is critical for tibial nonunion fracture in
neurofibromin-deficient mice. Hum Mol Genet. 22:4818–4828.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kolanczyk M, Kossler N, Kuhnisch J,
Lavitas L, Stricker S, Wilkening U, Manjubala I, Fratzl P, Sporle
R, Herrmann BG, et al: Multiple roles for neurofibromin in skeletal
development and growth. Hum Mol Genet. 16:874–886. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wu X, Estwick SA, Chen S, Yu M, Ming W,
Nebesio TD, Li Y, Yuan J, Kapur R, Ingram D, et al: Neurofibromin
plays a critical role in modulating osteoblast differentiation of
mesenchymal stem/progenitor cells. Hum Mol Genet. 15:2837–2845.
2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang W, Nyman JS, Ono K, Stevenson DA,
Yang X and Elefteriou F: Mice lacking Nf1 in osteochondroprogenitor
cells display skeletal dysplasia similar to patients with
neurofibromatosis type I. Hum Mol Genet. 20:3910–3924.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y, Li J, Zhou Q, Liu Y, Chen W and Xu
H: mTORC1 signaling is essential for neurofibromatosis type I gene
modulated osteogenic differentiation of BMSCs. J Cell Biochem.
120:2886–2896. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Reggiori F and Klionsky DJ: Autophagy in
the eukaryotic cell. Eukaryot Cell. 1:11–21. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wan Y, Zhuo N, Li Y, Zhao W and Jiang D:
Autophagy promotes osteogenic differentiation of human bone marrow
mesenchymal stem cell derived from osteoporotic vertebrae. Biochem
Biophys Res Commun. 488:46–52. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhou Z, Shi G, Zheng X, Jiang S and Jiang
L: Autophagy activation facilitates mechanical stimulation-promoted
osteoblast differentiation and ameliorates hindlimb
unloading-induced bone loss. Biochem Biophys Res Commun.
498:667–673. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lim HJ, Crowe P and Yang JL: Current
clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment
of human cancer. J Cancer Res Clin Oncol. 141:671–689.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Heras-Sandoval D, Perez-Rojas JM,
Hernandez-Damian J and Pedraza-Chaverri J: The role of
PI3K/AKT/mTOR pathway in the modulation of autophagy and the
clearance of protein aggregates in neurodegeneration. Cell Signal.
26:2694–2701. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rabanal-Ruiz Y, Otten EG and Korolchuk VI:
mTORC1 as the main gateway to autophagy. Essays Biochem.
61:565–584. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tan Q, Wu JY, Liu YX, Liu K, Tang J, Ye
WH, Zhu GH, Mei HB and Yang G: The neurofibromatosis type I gene
promotes autophagy via mTORC1 signalling pathway to enhance new
bone formation after fracture. J Cell Mol Med. 24:11524–11534.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao F, Feng G, Zhu J, Su Z, Guo R, Liu J,
Zhang H and Zhai Y: 3-Methyladenine-enhanced susceptibility to
sorafenib in hepatocellular carcinoma cells by inhibiting
autophagy. Anticancer Drugs. 32:386–393. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Song C, Song C and Tong F: Autophagy
induction is a survival response against oxidative stress in bone
marrow-derived mesenchymal stromal cells. Cytotherapy.
16:1361–1370. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shibutani ST, Saitoh T, Nowag H, Münz C
and Yoshimori T: Autophagy and autophagy-related proteins in the
immune system. Nat Immunol. 16:1014–1024. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang K, Guo W, Ren T, Huang Y, Han Y,
Zhang H and Zhang J: Knockdown of HMGA2 regulates the level of
autophagy via interactions between MSI2 and Beclin1 to inhibit
NF1-associated malignant peripheral nerve sheath tumour growth. J
Exp Clin Cancer Res. 38(185)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lopez G, Torres K, Liu J, Hernandez B,
Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon
IE, et al: Autophagic survival in resistance to histone deacetylase
inhibitors: Novel strategies to treat malignant peripheral nerve
sheath tumors. Cancer Res. 71:185–196. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
de la Croix Ndong J, Stevens DM, Vignaux
G, Uppuganti S, Perrien DS, Yang X, Nyman JS, Harth E and
Elefteriou F: Combined MEK inhibition and BMP2 treatment promotes
osteoblast differentiation and bone healing in Nf1Osx-/-mice. J
Bone Miner Res. 30:55–63. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ma Y, Qi M, An Y, Zhang L, Yang R, Doro
DH, Liu W and Jin Y: Autophagy controls mesenchymal stem cell
properties and senescence during bone aging. Aging Cell.
17(e12709)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nuschke A, Rodrigues M, Stolz DB, Chu CT,
Griffith L and Wells A: Human mesenchymal stem cells/multipotent
stromal cells consume accumulated autophagosomes early in
differentiation. Stem Cell Res Ther. 5(140)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu X, Wang Y, Cao Z, Dou C, Bai Y, Liu C,
Dong S and Fei J: Staphylococcal lipoteichoic acid promotes
osteogenic differentiation of mouse mesenchymal stem cells by
increasing autophagic activity. Biochem Biophys Res Commun.
485:421–426. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gomez-Puerto MC, Verhagen LP, Braat AK,
Lam EW, Coffer PJ and Lorenowicz MJ: Activation of autophagy by
FOXO3 regulates redox homeostasis during osteogenic
differentiation. Autophagy. 12:1804–1816. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chang H, Li X, Cai Q, Li C, Tian L, Chen
J, Xing X, Gan Y, Ouyang W and Yang Z: The PI3K/Akt/mTOR pathway is
involved in CVB3-induced autophagy of HeLa cells. Int J Mol Med.
40:182–192. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gao Y, Zhang Y and Fan Y: Eupafolin
ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via
PI3K/AKT/mTOR signaling pathway. Iran J Basic Med Sci.
22:1340–1346. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schulte A, Ewald F, Spyra M, Smit DJ,
Jiang W, Salamon J, Jucker M and Mautner VF: Combined targeting of
AKT and mTOR inhibits proliferation of human NF1-associated
malignant peripheral nerve sheath tumour cells in vitro but not in
a xenograft mouse model in vivo. Int J Mol Sci.
21(1548)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li XX, Zhang SJ, Chiu AP, Lo LH, Huang J,
Rowlands DK, Wang J and Keng VW: Targeting of AKT/ERK/CTNNB1 by
DAW22 as a potential therapeutic compound for malignant peripheral
nerve sheath tumor. Cancer Med. 7:4791–4800. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hosokawa N, Hara T, Kaizuka T, Kishi C,
Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et
al: Nutrient-dependent mTORC1 association with the
ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell.
20:1981–1991. 2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Blommaart EF, Krause U, Schellens JP,
Vreeling-Sindelarova H and Meijer AJ: The phosphatidylinositol
3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in
isolated rat hepatocytes. Eur J Biochem. 243:240–246.
1997.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Petiot A, Ogier-Denis E, Blommaart EF,
Meijer AJ and Codogno P: Distinct classes of phosphatidylinositol
3'-kinases are involved in signaling pathways that control
macroautophagy in HT-29 cells. J Biol Chem. 275:992–998.
2000.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wu YT, Tan HL, Shui G, Bauvy C, Huang Q,
Wenk MR, Ong CN, Codogno P and Shen HM: Dual role of
3-methyladenine in modulation of autophagy via different temporal
patterns of inhibition on class I and III phosphoinositide
3-kinase. J Biol Chem. 285:10850–10861. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li Y, Su J, Sun W, Cai L and Deng Z:
AMP-activated protein kinase stimulates osteoblast differentiation
and mineralization through autophagy induction. Int J Mol Med.
41:2535–2544. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen X, Sun K, Zhao S, Geng T, Fan X, Sun
S, Zheng M and Jin Q: Irisin promotes osteogenic differentiation of
bone marrow mesenchymal stem cells by activating autophagy via the
Wnt//β-catenin signal pathway. Cytokine. 136(155292)2020.PubMed/NCBI View Article : Google Scholar
|
